ROCK & ASSOCIATES for WELLNESS PHARMACY
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Appropriations and report language related to the funding of FDA as it affects compounding pharmacies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Health Issues HCR
Issues related to the NASEM report to the FDA on compounded bioidentical hormones, and on the implementation of the MOU under section 503A of the FDCA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Issues related to the federal regulation of compounding pharmacy. No specific legislation at this time.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.